Secobarbital Sodium

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Jul 19, 1950	Seconal SodiumNDA 7392 · New active ingredient	Lilly	3	Discontinued
Dec 3, 1973	Secobarbital SodiumANDA 83262	Wyeth Ayerst	4	Discontinued
Apr 7, 1975	Secobarbital SodiumANDA 84225	Barr	0	Discontinued
Dec 2, 1976	Secobarbital SodiumANDA 85285	Kv Pharm	0	Discontinued
Oct 25, 1977	Secobarbital SodiumANDA 85869	Ivax Pharms	0	Discontinued
Apr 24, 1978	Secobarbital SodiumANDA 85798	Whiteworth Town Plsn	0	Discontinued
Apr 24, 1978	Secobarbital SodiumANDA 85903	Lannett	0	Discontinued
Jun 8, 1978	Secobarbital SodiumANDA 85909	Lannett	0	Discontinued
Oct 30, 1978	Secobarbital SodiumANDA 85895	Everylife	0	Discontinued
Dec 10, 1981	Secobarbital SodiumANDA 85477	Valeant Pharm Intl	0	Discontinued
Oct 3, 1983	Seconal SodiumANDA 86101	Valeant Pharms North	15	Discontinued
—	Secobarbital SodiumANDA 83281	Elkins Sinn	0	Discontinued
—	Secobarbital SodiumANDA 84422	Anabolic	0	Discontinued
—	Secobarbital SodiumANDA 84561	Perrigo	0	Discontinued
—	Secobarbital SodiumANDA 84676	Halsey	0	Discontinued
—	Secobarbital SodiumANDA 84762	Parke Davis	0	Discontinued
—	Secobarbital SodiumANDA 84926	West Ward	0	Discontinued
—	Secobarbital SodiumANDA 85792	Watson Labs	0	Discontinued
—	Secobarbital SodiumANDA 85867	Purepac Pharm	0	Discontinued
—	Secobarbital SodiumANDA 85898	Vitarine	0	Discontinued
—	Secobarbital SodiumANDA 86273	Vitarine	0	Discontinued
—	Secobarbital SodiumANDA 86390	Wyeth Ayerst	0	Discontinued
—	Seconal SodiumANDA 86530	Lilly	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA